Related Experiment Videos
Pulmonary effects of furosemide in preterm infants with lung disease
Insights
Furosemide improved lung function in preterm infants with respiratory distress syndrome. This treatment enhanced pulmonary compliance and oxygenation, suggesting a direct lung effect beyond diuresis.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Pharmacology
Background:
- Respiratory distress syndrome (RDS) is a common condition in preterm infants.
- Infants recovering from RDS often experience persistent lung issues.
- Effective treatments to improve lung function in these infants are crucial.
Purpose of the Study:
- To investigate the effect of furosemide on lung function in preterm infants recovering from RDS.
- To determine if furosemide has a direct pulmonary effect independent of diuresis.
Main Methods:
- A randomized controlled study involving 20 preterm infants at 1 week of age recovering from RDS.
- Infants were assigned to either a control group or a treatment group receiving a single daily intravenous dose of furosemide (1 mg/kg).
- Pulmonary compliance and alveolar-arterial oxygen gradient were measured.
Main Results:
- Significant improvement in pulmonary compliance was observed at 2 hours in the furosemide-treated group compared to controls.
- The alveolar-arterial oxygen gradient decreased at 2 hours post-furosemide and remained lower over 4 days in the treated group.
- Lung function improvements were not attributed to diuresis.
Conclusions:
- Furosemide demonstrates a potential direct pulmonary effect in preterm infants with RDS.
- Acute and chronic administration of furosemide may improve lung function in this population.
- Further research into furosemide's pulmonary mechanisms is warranted.
Abstract:
Twenty preterm infants recovering from respiratory distress syndrome at 1 week of age were randomized in this study either to a control or a treatment group. Those treated received a single daily dose of furosemide (1 mg/kg) intravenously. Pulmonary compliance was observed to improve significantly at two hours in the treated group, as compared with that in the controls. The calculated alveolar-arterial oxygen gradient was noted to decrease two hours after furosemide and to remain decreased over the four-day period in the treated group. This improvement in lung function was not secondary to diuresis in the infants treated with furosemide. We conclude that furosemide may have a direct pulmonary effect and improve lung function acutely as well as with chronic administration.